News
Prophecy’s ‘future looking bright’ says Equitable Investors fundie
Every second week we invite a leading fund manager to present at The Insider: Meet the Fund Manager. In April 2023, we were joined by Martin Pretty, CFA, Founding Director and Investment Manager of Equitable Investors who chose Prophecy International…
US antimony stockpiles dwindle as Felix Gold hones in on domestic supply potential
In the midst of Felix Gold Ltd’s (ASX: FXG) Alaskan drilling campaign, it is worth delving into what the company considers to be potential to host a significant antimony (Sb) deposit, and how this plays into a global economy that is desperate for diversified sources of the critical mineral.
Record profits and technological innovation characterise post-covid travel recovery
Travel is on track to blast through its pre-pandemic levels, as the post-covid recovery has seen international arrivals data that shows the world is operating at 80% of what it was before the world ground to a halt. In the first quarter of 2023, an estimated 235 million tourists travelled internationally – more than double the amount during the same period in 2022. All up, data from 2022 showed over 960 million tourists travelling internationally last year.
New Zealand succumbs to rate hikes, natural disasters, enters recession
It’s official – Australia’s neighbour next door entered a technical recession last week after the country’s economy gave in to the aggressive cash rate hikes dished out by its central bank, aimed at curbing three-decade high inflation.
Masks off, smiles on: Japanese line up for $80 smiling lessons
“I hadn’t used my facial muscles much during COVID so it’s good exercise,” says 20-year-old Japanese student Himawari Yoshida in a country whose government recently lifted its recommendation to wear masks and where some people have forgotten how to smile.
Note from the MD: US market rally spurs on local traders
The US market’s rally continued overnight. The S&P 500 and Nasdaq climbed to year highs, bolstered by new data showing a slowdown in inflation, which in turn boosts hopes the Federal Reserve will leave interest rates on hold this week.
Selloff survivor poised to resume fight for pack leadership
Every second week we invite a leading fund manager to present at The Insider: Meet the Fund Manager. In April 2023, we were joined by Martin Pretty, CFA, Founding Director and Investment Manager of Equitable Investors who chose Mad Paws…
Apple corrects ‘autocorrect’ feature, ducking finally
Ever tried typing out a text on your phone referring to someone as ‘dear’ but ended up saying ‘dead’ instead? ‘Moist acne’ instead of ‘moustache’? ‘Duck’ instead of…? The company largely responsible for this long standing ‘duck’ up has decided to finally make amends.
Debt piling up across the United States, from the federal government to the average consumer
The US government debt ceiling has been at the forefront of financial media for the past few weeks. Now that it has been resolved (sort of), investors are turning their attention to household debt and if there is a ceiling that will make itself apparent at some point in the near future – ideally not in a GFC styled reveal.
Felix Gold looks to prove up resource next door to world class gold mine
Alaskan gold explorer Felix Gold (ASX: FXG) is now halfway through their 40 hole, 3,500m resource definition drilling program at their flagship Treasure Creek Project. The company expects assays to start rolling in towards the end of June, with newsflow being fairly consistent from then on. Felix is targeting a Maiden Mineral Resource Estimate (MRE) for the NW Array Southern Zone in Q4 CY2023.
New tumour destruction data for Prescient’s OmniCAR and CellPryme platforms
Clinical stage oncology company Prescient Therapeutics (ASX: PTX) presented exciting new data on their OmniCAR and CellPryme cell therapy platforms at the prestigious International Society of Cell & Gene Therapy (ISCT) in Paris earlier this month. The company is at the forefront of solving the critical challenges facing one of the world’s most exciting next-generation cancer therapies, CAR-T. OmniCAR has demonstrated a clear ability to drastically enhance CAR-T tumour killing abilities in glioblastoma and acute myeloid leukaemia.
Note from the MD: RBA’s rate hike & ongoing war on inflation, casts shadow over markets
Australian shares took a hit as interest rates rose to 4.1% yesterday, the highest cash rate since April 2012.
Connecting quality investors and innovative companies to facilitate mutual wealth creation with trust and transparency
Receive the latest news and media directly to your inbox
By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement.